Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act – Barron's
Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act Barron'sPfizer hikes full-year outlook as newer products grow, taps company veteran as new CFO CNBCPfizer increases annual profit forecast amid solid demand for blood thinner drug Yahoo FinancePfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results ReutersPfizer Raises Forecast on Momentum With New Products WSJ
সূত্র: মূল সংবাদসূত্র
